ORE PHARMACEUTICAL HOLDINGS INC. (CIK: 0001043914) EDGAR, Information, Filings... CompaniesBIO.Com

ORE PHARMACEUTICAL HOLDINGS INC.

Mailing address
ONE MAIN STREET, SUITE 300, CAMBRIDGE, Delaware, 02142
Phone
6176492001
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

ORE PHARMACEUTICAL HOLDINGS INC. (CIK: 0001043914) is an American company incorporated in the state of Massachusetts. Head office is located at ONE MAIN STREET, SUITE 300, CAMBRIDGE, Massachusetts, 02142. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. ORE PHARMACEUTICAL HOLDINGS INC. is a public company and trade via Over-The-Counter (OTC).

Old names:

ORE PHARMACEUTICALS INC. from 2009-21-Jul to 2009-18-Sep
GENE LOGIC INC from 1997-24-Nov to 2009-17-Jul

Owner	Filings	Transaction Date	Type of Owner
GIBSON TERRY	0001264193	Oct-29-2010	officer: CEO and CFO, other: See Explanation of Responses
LICHTENSTEIN WARREN G	0001005784	Oct-22-2010	10 percent owner
HOWARD JACK L	0001144269	Oct-22-2010	director, other: See Explanation of Responses
EMH Howard LLC	0001443099	Oct-22-2010	other: See Explanation of Responses
Kong Kenneth	0001504324	Oct-22-2010	director, other: See Explanation of Responses
Steel Partners, Ltd.	0001504325	Oct-22-2010	10 percent owner
FORDYCE JAMES W	0001094878	Jul-31-2009	director
Palleiko Benjamin L	0001366244	Jul-15-2009	officer: SVP & Chief Financial Officer
Dunne Chris T	0001461991	Apr-01-2009	officer: Principal Accounting Officer
Donahue Stephen R	0001462323	Mar-12-2009	officer: Senior Vice President
URDAL DAVID	0001242879	Apr-09-2007	director
Gabrielson Mark J	0001396131	Apr-09-2007	director
MILLER LLOYD I III	0000949119	Oct-20-2006	10 percent owner
Tiffany Larry M	0001368284	Jun-27-2006	officer: SVP & Interim GM Gemonics
Tartaglia Louis A	0001365332	Jun-01-2006	officer: SVP & GM Drug Repositioning
Brinkerhoff Van Wyck	0001319765	Mar-06-2005	officer: Sr. VP & General Manager
Barger Dennis	0001316290	Jan-26-2005	officer: VP Global Business Development
Douglas Frank L	0001310452	Nov-24-2004	director
ROSSI DENNIS	0001223360	Sep-17-2004	officer: GM Gene Logic Genomics
Smith-Farrell Joanne	0001304048	Sep-17-2004	officer: VP Corp Development & Strategy
DIMMLER CHARLES L III	0001032354	Jun-03-2004	director
DOLGINOW Y DOUGLAS MD	0001241140	Jun-03-2004	officer: Sr. VP Pharmacogenomics
BLAKE JULES PHD	0001241144	Jun-03-2004	director
GORRY G ANTHONY PHD	0001241145	Jun-03-2004	director
THOMPSON J STARK PHD	0001241146	Jun-03-2004	director
GESSLER MARK D	0001241136	Jul-31-2003	director, officer: CEO and President
ROHRER PHILIP L JR	0001241139	Jul-31-2003	officer: Chief Financial Officer
STAPLES F DUDLEY JR	0001241143	Jul-31-2003	officer: Senior VP, Secretary
PROULX ROBERT	0001252765	Jul-08-2003	officer: Senior Vice President
BRENNAN MICHAEL J	0001241260	Jun-13-2003	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ORE PHARMACEUTICAL HOLDINGS INC.

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001037389-11-000070 (34 Act) Size: 16 KB	Feb-11-2011	005-53373 11596680
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0000921895-10-001633 ( Act) Size: 4 KB	Nov-05-2010
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0000921895-10-001611 ( Act) Size: 6 KB	Nov-01-2010
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0000921895-10-001610 ( Act) Size: 4 KB	Nov-01-2010
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000921895-10-001608 (34 Act) Size: 419 KB	Nov-01-2010	005-53373 101155727
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000921895-10-001596 ( Act) Size: 8 KB	Oct-29-2010
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0000921895-10-001595 ( Act) Size: 6 KB	Oct-29-2010
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001157523-10-005617 (34 Act) Size: 3 KB	Sep-24-2010	000-23317 101089042
CT ORDER	Document	Acc-no: 9999999997-10-018086 (34 Act) Size: 19 KB	Sep-23-2010	000-23317 101087045
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001157523-10-004995 (34 Act) Size: 591 KB	Aug-11-2010	000-23317 101008124
8-K	Document	Current report filing Acc-no: 0001157523-10-004200 (34 Act) Size: 23 KB	Jul-22-2010	000-23317 10965021
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001157523-10-003059 (34 Act) Size: 353 KB	May-11-2010	000-23317 10820980
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001157523-10-002542 (34 Act) Size: 377 KB	Apr-29-2010	000-23317 10782363
8-K	Document	Current report filing Acc-no: 0001157523-10-002109 (34 Act) Size: 23 KB	Apr-19-2010	000-23317 10757468
25-NSE	Document	Acc-no: 0001354457-10-000082 (34 Act) Size: 4 KB	Apr-05-2010	000-23317
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001157523-10-001855 (34 Act) Size: 1101 KB	Mar-31-2010	000-23317 10720533
8-K	Document	Current report filing Acc-no: 0001157523-10-001660 (34 Act) Size: 15 KB	Mar-22-2010	000-23317 10696692
8-K	Document	Current report filing Acc-no: 0001157523-10-000888 (34 Act) Size: 5 KB	Feb-12-2010	000-23317 10600651
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001037389-10-000248 (34 Act) Size: 13 KB	Feb-12-2010	005-53373 10594803
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000354204-10-001308 (34 Act) Size: 51 KB	Feb-08-2010	005-53373 10579712

Recent 20 filings. View all ORE PHARMACEUTICAL HOLDINGS INC. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

ORE PHARMACEUTICAL HOLDINGS INC. overview
ORE PHARMACEUTICAL HOLDINGS INC. job
ORE PHARMACEUTICAL HOLDINGS INC. stock
ORE PHARMACEUTICAL HOLDINGS INC. ownership
ORE PHARMACEUTICAL HOLDINGS INC. CEO
ORE PHARMACEUTICAL HOLDINGS INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.